Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of Murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 140 (2), 557-564
- https://doi.org/10.1016/0006-291x(86)90768-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Evaluation of the Immunoadjuvant Murabutide, a Derivative of MDP, Administered with a Tetanus Toxoid VaccineThe Journal of Infectious Diseases, 1986
- Hepatitis B virus contains pre-S gene-encoded domainsNature, 1985
- Detection of antibodies directed against the pre-S gene product of hepatitis B virus: Relationship between anti-pre-S response and recoveryAnnales de l'Institut Pasteur / Immunologie, 1985
- Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigensInfection and Immunity, 1984
- Location and Chemical Synthesis of a Pre-S Gene Coded Immunodominant Epitope of Hepatitis B VirusScience, 1984
- Antibody response to two synthetic peptides corresponding to residues 45–68 and 69–79 of the major protein of hepatitis B surface antigenVirus Research, 1984
- Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicityInfection and Immunity, 1982
- Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptidesJournal of Medicinal Chemistry, 1982
- Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M proteinNature, 1981
- Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.Proceedings of the National Academy of Sciences, 1981